Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SYMPHONY Extension: Macitentan in PAH
NCT01847014Phase 3Terminated
- Sponsor
- Actelion Pharmaceuticals Ltd
- Start
- Sep 2013
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of macitentan in pulmonary arterial hypertension (PAH), sponsored by Actelion Pharmaceuticals Ltd. Started Sep 2013; status: terminated.
02
Drugs
macitentan
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT01847014.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01847014.